GL1X · GenesisL1 explorer

MolNFT v1 · #114636 · protein

Fragment-based discovery of potent and selective DDR1/2 inhibitors

5BVK · Epithelial discoidin domain-containing receptor 1: “Fragment-based discovery of potent and selective DDR1/2 inhibitors”. X-ray diffraction, 2 ligands (4VC, IOD), 1 pocket (best druggability 0.74). MolNFT v1 #114636 on GenesisL1: 3D…

PDB
5BVK
Type
protein
Length
278 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Epithelial discoidin domain-containing receptor 1
EC
2.7.10.1
UniProt
Q08345
Ligands
4VC, IOD
Pockets
1 · best druggability 0.74

Structure

x-ray diffraction · 1 distinct chain · 42% helix, 18% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AEpithelial discoidin domain-containing receptor 1 (EC 2.7.10.1)protein27842% helix, 18% strandQ08345

Ligands and binding sites

  • 4VC · 1-(2-chlorophenyl)-3-(pyridin-3-ylmethyl)urea · ligand · chains A
  • IOD · Iodide ion · ion · 6 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
14530.740.8358IOD, 4VC

Compared structures

  • 5BVK · Fragment-based discovery of potent and selective DDR1/2 inhibitors · the same entry in another collection · chain A against A, TM-score 1.00
  • Q08345 · AlphaFold monomer V2.0 prediction for epithelial discoidin domain- containing receptor 1… · a predicted model of the same protein · chain A against A, TM-score 0.98

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.